Literature DB >> 28538787

Cost-effectiveness thresholds and the Brazilian Unified National Health System.

Patricia Coelho De Soarez1, Hillegonda Maria Dutilh Novaes1.   

Abstract

Mesh：

Year:  2017        PMID： 28538787     DOI： 10.1590/0102-311X00040717

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN： 0102-311X            Impact factor:   1.632


× No keyword cloud information.
  13 in total

Review 1.  Cost-Effectiveness Thresholds: the Past, the Present and the Future.

Authors:  Praveen Thokala; Jessica Ochalek; Ashley A Leech; Thaison Tong
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

2.  Cost-Utility of Gastric Bypass Surgery Compared to Clinical Treatment for Severely Obese With and Without Diabetes in the Perspective of the Brazilian Public Health System.

Authors:  Roberto Pereira Assumpção; Luciana Ribeiro Bahia; Michelle Quarti Machado da Rosa; Marcelo Goulart Correia; Everton Nunes da Silva; Paula Rosales Zubiaurre; Claudio Corá Mottin; Denizar Araujo Vianna
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

3.  Responsible innovation in health and health system sustainability: Insights from health innovators' views and practices.

Authors:  Pascale Lehoux; Hudson P Silva; Robson Rocha de Oliveira; Renata P Sabio; Kathy Malas
Journal:  Health Serv Manage Res       Date:  2021-12-05

4.  Transforming Disciplinary Traditions Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".

Authors:  Pascale Lehoux; Hudson Silva
Journal:  Int J Health Policy Manag       Date:  2020-07-01

Review 5.  PCSK9 Inhibitors: Clinical Relevance, Molecular Mechanisms, and Safety in Clinical Practice.

Authors:  Filipe Ferrari; Ricardo Stein; Marcelo Trotte Motta; Emilio Hideyuki Moriguchi
Journal:  Arq Bras Cardiol       Date:  2019-02-28       Impact factor: 2.000

6.  Cost-Effectiveness Analysis of Influenza A (H1N1) Chemoprophylaxis in Brazil.

Authors:  Luisa von Zuben Vecoso; Marcus Tolentino Silva; Mariangela Ribeiro Resende; Everton Nunes da Silva; Tais Freire Galvao
Journal:  Front Pharmacol       Date:  2019-09-10       Impact factor: 5.810

7.  Cost-effectiveness of serological tests for human visceral leishmaniasis in the Brazilian scenario.

Authors:  Mariana Lourenço Freire; Aline de Souza; Gláucia Cota; Ana Rabello; Tália Machado de Assis
Journal:  PLoS Negl Trop Dis       Date:  2020-10-08

Review 8.  Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies.

Authors:  Carlos Barrios; Ruffo Freitas-Junior; Sandro Martins; Jose Bines; Maria Del Pilar Estevez-Diz; Maira Caleffi
Journal:  JCO Glob Oncol       Date:  2021-04

9.  Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.

Authors:  Tania Yuka Yuba; Hillegonda Maria Dutilh Novaes; Patrícia Coelho de Soárez
Journal:  Health Res Policy Syst       Date:  2018-05-11

10.  Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil.

Authors:  Jasper Ubels; Craig Sable; Andrea Z Beaton; Maria Carmo P Nunes; Kaciane K B Oliveira; Lara C Rabelo; Isabella M Teixeira; Gabriela Z L Ruiz; Letícia Maria M Rabelo; Alison R Tompsett; Antonio Luiz P Ribeiro; Klas-Göran Sahlen; Bruno R Nascimento
Journal:  Glob Heart       Date:  2020-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.